Comprehensive clinical assays for molecular diagnostics of gliomas: the current state and future prospects

Comprehensive clinical assays for molecular diagnostics of gliomas: the current state and future prospects

Glioma is one of the most intractable types of cancer, due to delayed diagnosis at advanced stages. The clinical symptoms of glioma are unclear and due to a variety of glioma subtypes, available low-invasive testing is not effective enough to be introduced into routine medical laboratory practice. T...

Full description

Bibliographic Details
Main Authors:	Alina Penkova, Olga Kuziakova, Valeriia Gulaia, Vladlena Tiasto, Nikolay V. Goncharov, Daria Lanskikh, Valeriia Zhmenia, Ivan Baklanov, Vladislav Farniev, Vadim Kumeiko
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-10-01
Series:	Frontiers in Molecular Biosciences
Subjects:	cancer molecular diagnostics NGS panel PCR molecular markers of glioma medical market
Online Access:	https://www.frontiersin.org/articles/10.3389/fmolb.2023.1216102/full

Similar Items

Towards an advanced cell-based <em>in vitro</em> glioma model system
by: Valeriia Mikhailova, et al.
Published: (2018-03-01)

Cell and Tissue Nanomechanics: From Early Development to Carcinogenesis
by: Mikhail E. Shmelev, et al.
Published: (2022-02-01)

Single-nucleus transcriptomics of IDH1- and TP53-mutant glioma stem cells displays diversified commitment on invasive cancer progenitors
by: Valeriia Gulaia, et al.
Published: (2022-11-01)

Author Correction: Single-nucleus transcriptomics of IDH1- and TP53-mutant glioma stem cells displays diversified commitment on invasive cancer progenitors
by: Valeriia Gulaia, et al.
Published: (2023-02-01)

Comprehensive Molecular Characterization of Chinese Patients with Glioma by Extensive Next-Generation Sequencing Panel Analysis
by: Zeng C, et al.
Published: (2021-04-01)

Nanomechanical Signatures in Glioma Cells Depend on CD44 Distribution in IDH1 Wild-Type but Not in IDH1R132H Mutant Early-Passage Cultures
by: Mikhail E. Shmelev, et al.
Published: (2023-02-01)

Molecular Mechanisms Governing the Stem Cell’s Fate in Brain Cancer: Factors of Stemness and Quiescence
by: Valeriia Gulaia, et al.
Published: (2018-11-01)

Nanomechanical and Morphological AFM Mapping of Normal Tissues and Tumors on Live Brain Slices Using Specially Designed Embedding Matrix and Laser-Shaped Cantilevers
by: Vladislav M. Farniev, et al.
Published: (2022-07-01)

Novel assay to measure chromosome instability identifies Punica granatum extract that elevates CIN and has a potential for tumor- suppressing therapies
by: Nikolay V. Goncharov, et al.
Published: (2022-12-01)

Molecular and clinicopathologic features of gliomas harboring NTRK fusions
by: Matthew Torre, et al.
Published: (2020-07-01)

CLINICAL RELEVANCE OF MOLECULAR MARKERS IN GLIOMAS
by: Varun Monga, MBBS, et al.
Published: (2017-05-01)

Anatomic mapping of molecular subtypes in diffuse glioma
by: Qisheng Tang, et al.
Published: (2017-09-01)

Next generation sequencing in sudden cardiac death (pilot study)
by: V. N. Maksimov, et al.
Published: (2020-11-01)

Gliomas malignos: biología molecular y detalles oncogenéticos
by: Enrique Marcos Sierra Benítez, et al.

Molecular classification of diffuse gliomas
by: Arvids Jakovlevs, et al.
Published: (2020-03-01)

Role of molecular biomarkers in glioma resection: a systematic review
by: Lianwang Li, et al.
Published: (2020-05-01)

Molecular testing approaches in thyroid cancer diagnosis
by: Abdul-Mohsen Gaeth AlHejaily, et al.
Published: (2020-12-01)

Clinical value of molecular pathology in glioma
by: Tian⁃ming QIU, et al.
Published: (2019-11-01)

Perfusion CT detects alterations in local cerebral flow of glioma related to IDH, MGMT and TERT status
by: Ke Wang, et al.
Published: (2021-11-01)

Significantly high expression of NUP37 leads to poor prognosis of glioma patients by promoting the proliferation of glioma cells
by: Zhendong Liu, et al.
Published: (2021-08-01)

Diagnostic Yield and Complication Rate of Stereotactic Biopsies in Precision Medicine of Gliomas
by: Sophie Katzendobler, et al.
Published: (2022-03-01)

Clinical evaluation of a dedicated next generation sequencing panel for routine glioma diagnostics
by: Nathalie E. Synhaeve, et al.
Published: (2018-11-01)

Gene discovery in glioma in the context of molecular reclassification of tumors
by: Khushboo Irshad, et al.
Published: (2015-12-01)

Novel Pathogenic Variants in Hereditary Cancer Syndromes in a Highly Heterogeneous Cohort of Patients: Insights from Multigene Analysis
by: Airat Bilyalov, et al.
Published: (2023-12-01)

Molecular Biomarkers and Recent Liquid Biopsy Testing Progress: A Review of the Application of Biosensors for the Diagnosis of Gliomas
by: Yuanbin Wu, et al.
Published: (2023-07-01)

Invertebrate C1q Domain-Containing Proteins: Molecular Structure, Functional Properties and Biomedical Potential
by: Andrei Grinchenko, et al.
Published: (2023-10-01)

Diagnosis of Glioma Molecular Markers by Terahertz Technologies
by: Olga Cherkasova, et al.
Published: (2021-01-01)

Common Molecular Alterations in Canine Oligodendroglioma and Human Malignant Gliomas and Potential Novel Therapeutic Targets
by: Dana Mitchell, et al.
Published: (2019-08-01)

Looking through the imaging perspective: the importance of imaging necrosis in glioma diagnosis and prognostic prediction – single centre experience
by: Ma Hui, et al.
Published: (2024-02-01)

Expression and Prognostic Value of Inward Rectifier Potassium Channel Subfamily J Member 11 mRNA in Gliomas
by: WANG Fang, et al.
Published: (2022-01-01)

Ferroptosis and Its Potential Role in Glioma: From Molecular Mechanisms to Therapeutic Opportunities
by: Yusong Luo, et al.
Published: (2022-10-01)

Pediatric Glioma: An Update of Diagnosis, Biology, and Treatment
by: Yusuke Funakoshi, et al.
Published: (2021-02-01)

Current Progress in Treatment of Glioma
by: ZHANG Yu, et al.
Published: (2022-06-01)

Pediatric high-grade glioma: A heterogeneous group of neoplasms with different molecular drivers
by: Francesca Gianno, et al.
Published: (2018-01-01)

Therapeutic Targets in Diffuse Midline Gliomas—An Emerging Landscape
by: Elisha Hayden, et al.
Published: (2021-12-01)

The potential effect of APTR amplification on glioma patients' prognosis
by: Shan⁃shan ZHANG, et al.
Published: (2019-07-01)

Visualization of Diagnostic and Therapeutic Targets in Glioma With Molecular Imaging
by: Deling Li, et al.
Published: (2020-10-01)

The Glioma-IRE project − Molecular profiling in patients with glioma: steps toward an individualized diagnostic and therapeutic approach
by: Veronica Villani, et al.
Published: (2023-03-01)

Editorial: Research progress on immune microenvironment and molecular mechanism of glioma
by: Hany E. Marei, et al.
Published: (2023-10-01)

Anoikis resistance in diffuse glioma: The potential therapeutic targets in the future
by: Zhengyang Zhu, et al.
Published: (2022-08-01)